420 related articles for article (PubMed ID: 29520274)
1. Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.
Iezzi ME; Policastro L; Werbajh S; Podhajcer O; Canziani GA
Front Immunol; 2018; 9():273. PubMed ID: 29520274
[TBL] [Abstract][Full Text] [Related]
2. Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.
De Vos J; Devoogdt N; Lahoutte T; Muyldermans S
Expert Opin Biol Ther; 2013 Aug; 13(8):1149-60. PubMed ID: 23675652
[TBL] [Abstract][Full Text] [Related]
3. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
[TBL] [Abstract][Full Text] [Related]
4. Antigen recognition by single-domain antibodies: structural latitudes and constraints.
Henry KA; MacKenzie CR
MAbs; 2018; 10(6):815-826. PubMed ID: 29916758
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and humanization of single-domain antibodies.
Rossotti MA; Bélanger K; Henry KA; Tanha J
FEBS J; 2022 Jul; 289(14):4304-4327. PubMed ID: 33751827
[TBL] [Abstract][Full Text] [Related]
6. Single-domain antibodies and their utility.
Baral TN; MacKenzie R; Arbabi Ghahroudi M
Curr Protoc Immunol; 2013 Nov; 103():2.17.1-2.17.57. PubMed ID: 24510545
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.
Al Qaraghuli MM; Ferro VA
J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27862476
[TBL] [Abstract][Full Text] [Related]
8. Generation of single-domain antibody multimers with three different self-associating peptides.
Wang L; Liu X; Zhu X; Wang L; Wang W; Liu C; Cui H; Sun M; Gao B
Protein Eng Des Sel; 2013 Jun; 26(6):417-23. PubMed ID: 23538432
[TBL] [Abstract][Full Text] [Related]
9. Single domain antibodies for the knockdown of cytosolic and nuclear proteins.
Böldicke T
Protein Sci; 2017 May; 26(5):925-945. PubMed ID: 28271570
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
11. Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect.
Chen T; Liu X; Hong H; Wei H
J Transl Med; 2020 Oct; 18(1):376. PubMed ID: 33023595
[TBL] [Abstract][Full Text] [Related]
12. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
[TBL] [Abstract][Full Text] [Related]
13. Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris.
Rahbarizadeh F; Rasaee MJ; Forouzandeh M; Allameh AA
Mol Immunol; 2006 Feb; 43(5):426-35. PubMed ID: 16337485
[TBL] [Abstract][Full Text] [Related]
14. RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.
Yu F; Wang Y; Xiao Y; He Y; Luo C; Duan D; Li C; Xu S; Xiang T
Mol Immunol; 2014 May; 59(1):100-9. PubMed ID: 24534066
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20.
Krasniqi A; Bialkowska M; Xavier C; Van der Jeught K; Muyldermans S; Devoogdt N; D'Huyvetter M
N Biotechnol; 2018 Oct; 45():69-79. PubMed ID: 29574274
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.
Goldman ER; Liu JL; Zabetakis D; Anderson GP
Front Immunol; 2017; 8():865. PubMed ID: 28791022
[TBL] [Abstract][Full Text] [Related]
17. A guide to: generation and design of nanobodies.
Muyldermans S
FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
[TBL] [Abstract][Full Text] [Related]
18. The development of nanobodies for therapeutic applications.
Van Bockstaele F; Holz JB; Revets H
Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
[TBL] [Abstract][Full Text] [Related]
19. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
20. Single domain antibodies: a new concept for epidermal growth factor receptor and EGFRvIII targeting.
Omidfar K; Shirvani Z
DNA Cell Biol; 2012 Jun; 31(6):1015-26. PubMed ID: 22277093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]